See more : Zhejiang Founder Motor Co., Ltd. (002196.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of LEOCLAN Co.,Ltd. (7681.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LEOCLAN Co.,Ltd., a leading company in the Healthcare industry within the Healthcare sector.
- China Creative Global Holdings Limited (1678.HK) Income Statement Analysis – Financial Results
- PT AKR Corporindo Tbk (PKCPY) Income Statement Analysis – Financial Results
- Cia. Hering (HGTX3.SA) Income Statement Analysis – Financial Results
- Amarc Resources Ltd. (AHR.V) Income Statement Analysis – Financial Results
- Modern Plant Based Foods Inc. (MDRNF) Income Statement Analysis – Financial Results
LEOCLAN Co.,Ltd. (7681.T)
About LEOCLAN Co.,Ltd.
LEOCLAN Co.,Ltd. operates as a medical equipment trading company that meets various medical care, welfare, and health needs. It operates through three segments: Medical Total Solutions Business, Remote Image Diagnosis Service Business, and School Lunch Business. The Medical Total Solutions Business segment provides incidental maintenance services; and interior decoration construction and installation works for medical institutions, preventive/health checkup facilities, nursing care/welfare facilities, etc. based on consulting services such as selection of medical equipment, as well as sells medical equipment and medical information systems. The Remote Image Diagnosis Service Business segment offers services in which diagnostic radiology specialists remotely diagnose image data taken by MRI, CT, etc., and provides information. The School Lunch Business segment provides school lunch services, including regular meals, medical meals, and other meals to nursing care and welfare facilities. LEOCLAN Co.,Ltd. was incorporated in 2001 and is headquartered in Settsu, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 26.63B | 29.77B | 26.35B | 22.00B | 36.11B |
| Cost of Revenue | 23.81B | 26.71B | 23.61B | 19.74B | 32.76B |
| Gross Profit | 2.82B | 3.06B | 2.73B | 2.26B | 3.35B |
| Gross Profit Ratio | 10.58% | 10.27% | 10.37% | 10.25% | 9.27% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 2.38B | 2.40B | 2.16B | 2.05B | 2.16B |
| Other Expenses | 1.00M | 53.35M | 1.32M | -3.04M | 0.00 |
| Operating Expenses | 2.38B | 2.40B | 2.16B | 2.05B | 2.16B |
| Cost & Expenses | 26.19B | 29.12B | 25.77B | 21.79B | 34.92B |
| Interest Income | 100.00K | 750.00K | 760.00K | 785.00K | 762.00K |
| Interest Expense | 840.00K | 1.12M | 1.54M | 2.30M | 2.95M |
| Depreciation & Amortization | 104.43M | 96.28M | 94.80M | 92.41M | 120.65M |
| EBITDA | 536.93M | 789.06M | 692.94M | 303.95M | 1.33B |
| EBITDA Ratio | 2.02% | 2.72% | 2.60% | 1.37% | 3.63% |
| Operating Income | 440.30M | 650.98M | 576.06M | 204.37M | 1.19B |
| Operating Income Ratio | 1.65% | 2.19% | 2.19% | 0.93% | 3.30% |
| Total Other Income/Expenses | -8.64M | 38.68M | 18.55M | 2.87M | -532.00K |
| Income Before Tax | 431.66M | 689.66M | 594.60M | 207.24M | 1.19B |
| Income Before Tax Ratio | 1.62% | 2.32% | 2.26% | 0.94% | 3.29% |
| Income Tax Expense | 145.90M | 219.13M | 184.20M | 74.90M | 434.83M |
| Net Income | 271.31M | 437.05M | 390.98M | 120.84M | 732.96M |
| Net Income Ratio | 1.02% | 1.47% | 1.48% | 0.55% | 2.03% |
| EPS | 138.37 | 222.90 | 199.92 | 62.51 | 376.84 |
| EPS Diluted | 137.52 | 221.52 | 198.33 | 61.85 | 376.84 |
| Weighted Avg Shares Out | 1.96M | 1.96M | 1.96M | 1.93M | 1.95M |
| Weighted Avg Shares Out (Dil) | 1.97M | 1.97M | 1.97M | 1.95M | 1.95M |
Source: https://incomestatements.info
Category: Stock Reports